458 related articles for article (PubMed ID: 20133979)
1. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
2. The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
Sobczuk A; Romanowicz H; Fiks T; Połać I; Smolarz B
Pol J Pathol; 2009; 60(4):163-7. PubMed ID: 20072949
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
[TBL] [Abstract][Full Text] [Related]
4. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
[TBL] [Abstract][Full Text] [Related]
6. [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].
Hu MB; Xie W; Xiong B; Han DF; Li Y; Feng MH; Zhou YF
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):351-5. PubMed ID: 16875543
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between estrogen-biosynthesis gene (CYP17, CYP19, HSD17beta1) polymorphisms and breast cancer].
Wang YP; Li H; Li JY; Yuan P; Yang F; Lei FM; Pang Y; Guo J
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):899-903. PubMed ID: 20193327
[TBL] [Abstract][Full Text] [Related]
8. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients.
Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A
Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881
[TBL] [Abstract][Full Text] [Related]
9. CYP17 (T34C), CYP19 (Trp39Arg), and FGFR2 (C906T) polymorphisms and the risk of breast cancer in south Indian women.
Samson M; Rama R; Swaminathan R; Sridevi V; Nancy KN; Rajkumar T
Asian Pac J Cancer Prev; 2009; 10(1):111-4. PubMed ID: 19469636
[TBL] [Abstract][Full Text] [Related]
10. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity.
Berstein LM; Imyanitov EN; Kovalevskij AJ; Maximov SJ; Vasilyev DA; Buslov KG; Sokolenko AP; Iyevleva AG; Chekmariova EV; Thijssen JH
Cancer Lett; 2004 Apr; 207(2):191-6. PubMed ID: 15072828
[TBL] [Abstract][Full Text] [Related]
11. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
[TBL] [Abstract][Full Text] [Related]
12. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer.
Farzaneh F; Noghabaei G; Barouti E; Pouresmaili F; Jamshidi J; Fazeli A; Emamalizadeh B; Darvish H
Asian Pac J Cancer Prev; 2016; 17(S3):23-6. PubMed ID: 27165202
[TBL] [Abstract][Full Text] [Related]
14. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H
Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822
[TBL] [Abstract][Full Text] [Related]
16. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
[TBL] [Abstract][Full Text] [Related]
17. [Association of polymorphism of genetic markers of CYP19 and CYP17 with sporadic breast cancer].
Artamonov VV; Liubchenko LN; Shabanov MA; Babenko OV; Nemtsova MV; Zaletaev DV
Mol Biol (Mosk); 2003; 37(6):975-82. PubMed ID: 14714492
[TBL] [Abstract][Full Text] [Related]
18. Association of the CYP17 MSP AI (T-34C) and CYP19 codon 39 (Trp/Arg) polymorphisms with susceptibility to acne vulgaris.
Chamaie-Nejad F; Saeidi S; Najafi F; Ebrahimi A; Rahimi Z; Shakiba E; Rahimi Z
Clin Exp Dermatol; 2018 Mar; 43(2):183-186. PubMed ID: 29285776
[TBL] [Abstract][Full Text] [Related]
19. PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.
dos Santos RM; de Jesus CM; Trindade Filho JC; Trindade JC; de Camargo JL; Rainho CA; Rogatto SR
DNA Cell Biol; 2008 Sep; 27(9):497-503. PubMed ID: 18491956
[TBL] [Abstract][Full Text] [Related]
20. Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study.
Ahsan H; Whittemore AS; Chen Y; Senie RT; Hamilton SP; Wang Q; Gurvich I; Santella RM
Breast Cancer Res; 2005; 7(1):R71-81. PubMed ID: 15642171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
